These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 4450660

  • 1. [Conservative therapy of chronic arterial occlusive diseases using subcutaneous administration of the rheologically effective snake venom Arwin].
    Ehrly AM, Breddin K.
    Verh Dtsch Ges Kreislaufforsch; 1974; 40():243-5. PubMed ID: 4450660
    [No Abstract] [Full Text] [Related]

  • 2. [Experiences with arwin in combination with thrombolytic therapy].
    Keil-Kuri E, Hess H.
    Verh Dtsch Ges Inn Med; 1974; 80():1470-2. PubMed ID: 4454460
    [No Abstract] [Full Text] [Related]

  • 3. [Therapy of chronic peripheral arterial occlusive diseases with snake venom enzyme Arwin].
    Ehrly AM.
    Med Welt; 1975 Mar 07; 26(10):446-55. PubMed ID: 1123988
    [No Abstract] [Full Text] [Related]

  • 4. [Dose-response relationship of subcutaneously administered Arwin in patients with chronic arterial blood circulation disorders].
    Ehrly AM.
    Vasa; 1975 Mar 07; 4(2):161-7. PubMed ID: 1136569
    [No Abstract] [Full Text] [Related]

  • 5. [Therapeutic defibrination using snake venom (Arvin) in arterial circulation disorders].
    Ehringer H, Dudczak E, Lechner K, Widhalm F.
    Verh Dtsch Ges Inn Med; 1972 Mar 07; 78():624-7. PubMed ID: 4677225
    [No Abstract] [Full Text] [Related]

  • 6. [Letter: Therapeutic defibrination with Ancrod].
    Ehrly AM.
    Dtsch Med Wochenschr; 1974 Jan 18; 99(3):112-3. PubMed ID: 4812781
    [No Abstract] [Full Text] [Related]

  • 7. [Defibrination with the snake venom enzyme arwin in peripheral arterial obstructive disease. Possibilities and limitations (author's transl)].
    Böhme H, Schmidt P, Hüttel E.
    MMW Munch Med Wochenschr; 1978 Nov 10; 120(45):1501-4. PubMed ID: 101819
    [Abstract] [Full Text] [Related]

  • 8. [Possibilities of the clinical use of a purified fraction of Agkistrodon rhodostoma venom in anticoagulant therapy].
    Isidori A, Fischetti I, Pallotta S, Piro C.
    Minerva Med; 1974 Dec 12; 65(89):4656-70. PubMed ID: 4437809
    [No Abstract] [Full Text] [Related]

  • 9. [Therapeutic defibrination with ancrod (author's transl)].
    Ehringer H, Dudczak R, Lechner K.
    Dtsch Med Wochenschr; 1973 Nov 30; 98(48):2298-304. PubMed ID: 4797013
    [No Abstract] [Full Text] [Related]

  • 10. Snake venom fibrin(ogen)olytic enzymes.
    Swenson S, Markland FS.
    Toxicon; 2005 Jun 15; 45(8):1021-39. PubMed ID: 15882884
    [Abstract] [Full Text] [Related]

  • 11. [Improvement of blood viscosity through Arvin].
    Ehrly AM, Breddin K.
    Verh Dtsch Ges Inn Med; 1972 Jun 15; 78():620-4. PubMed ID: 4677224
    [No Abstract] [Full Text] [Related]

  • 12. Snake venom as therapeutic agents: from toxin to drug development.
    Pal SK, Gomes A, Dasgupta SC, Gomes A.
    Indian J Exp Biol; 2002 Dec 15; 40(12):1353-8. PubMed ID: 12974396
    [Abstract] [Full Text] [Related]

  • 13. [is there a treatment for peripheral arterial insufficiency?].
    Zicot M.
    Rev Med Liege; 1979 Jan 15; 34(2):48-51. PubMed ID: 368938
    [No Abstract] [Full Text] [Related]

  • 14. Arwin in peripheral arterial circulatory disorders: controlled multicentre trials.
    Wolf GK.
    Eur J Clin Pharmacol; 1976 Mar 22; 09(5-6):387-92. PubMed ID: 786664
    [Abstract] [Full Text] [Related]

  • 15. [Long-term treatment using Arwin of patients with chronic peripheral arterial blood circulation disorders].
    Ehrly AM.
    Subsid Med; 1974 Mar 22; 4():56-7. PubMed ID: 4548779
    [No Abstract] [Full Text] [Related]

  • 16. Practical applications of snake venom toxins in haemostasis.
    Marsh NA, Fyffe TL.
    Boll Soc Ital Biol Sper; 1996 Mar 22; 72(9-10):263-78. PubMed ID: 9425723
    [Abstract] [Full Text] [Related]

  • 17. [Improvement of flow properties of human blood by subcutaneous administration of arwin].
    Ehrly AM, Jung HJ.
    Verh Dtsch Ges Inn Med; 1973 Mar 22; 79():1397-400. PubMed ID: 4799541
    [No Abstract] [Full Text] [Related]

  • 18. Report of the task force on clinical use of snake venom enzymes.
    Latallo ZS.
    Thromb Haemost; 1978 Jun 30; 39(3):768-74. PubMed ID: 705705
    [No Abstract] [Full Text] [Related]

  • 19. Systemic pathological alterations caused by Philodryas patagoniensis colubrid snake venom in rats.
    Peichoto ME, Teibler P, Ruíz R, Leiva L, Acosta O.
    Toxicon; 2006 Oct 30; 48(5):520-8. PubMed ID: 16911815
    [Abstract] [Full Text] [Related]

  • 20. [Improvement of flow properties of blood: a new principle for drug therapy of chronic peripheral arterial vascular disorders].
    Ehrly AM.
    Vasa Suppl; 1973 Oct 30; 1():1-18. PubMed ID: 4517911
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.